Europa Trial
Home
Sitemap
General Public Heathcare Professionals Virtual Press Office

New Indication in CAD New!

EUROPA calendar
ACC 2006 - Posters New!
ESC 2005 - Symposium
ESC 2005 - Oral sessions
ESC 2005 - Posters
AHA 2004 - Oral Session
ESC 2004 - Hotline
ESC 2004 - Symposium
ACC 2004
ESC 2003


EUROPA study
EUROPA Results
ESC 2003 Hotline - video
Rationale for EUROPA
Rationale for Perindopril
Design & Organisation
EUROPA investigators
EUROPA collaborating centres
EUROPA Recruitment


EUROPA Slide Set
Rationale and Design
Results
Clinical Implications


EUROPA publications


PERSUADE
PERSUADE Publications New!
PERSUADE Results
PERSUADE Fact Sheet


PERTINENT
PERTINENT Results
PERTINENT Fact Sheet


Background : Coronary Artery Disease
Home : Healthcare professionals : AHA 2004 - Oral Session
AHA 2004 - Oral Session




Tuesday, November 9, 2004
Place 261-262
Oral sessions

Session Title: Novel approaches to coronary disease



16:30 : Prevention of cardiovascular events by Perindopril in patients with stable coronary disease does not depend on blood pressure and its reduction-results from the EUROPA* study.

Prof W.Remme (Rotterdam, The Netherlands)


* The EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease


This website is intended for an international audience. Drug related information may refer to unlicensed products or uses which may not be approved in your own country and you should therefore consult your local prescribing information.
This site is published and updated by the EUROPA study investigators. Site last updated March 21st 2006
Terms of use - ©2005 EUROPA All rights reserved